| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Chromogranin A is a well-known protein constituent in granules of neuroendocrine cells. It is also known that plasma levels of chromogranin A increase considerably in patients with neuroendocrine tumours and thus chromogranin A is used as a marker for these tumours. In the present study, we have shown that fragments of chromogranin A are excreted into the urine in some patients with carcinoid tumours. The chromogranin A molecule appeared in the urine N-terminally cleaved at amino acid positions 116 and 210, which are previously reported cleavage sites of the molecule. The fragments identified were mainly of about 35 kDa in size. The unprocessed chromogranin A molecule was not excreted in the urine. Five out of 40 patients excreting the fragments had slight tubular dysfunction in the kidneys. We also showed that these renally excreted split products of chromogranin A were immunogenic and could be used for production of antibodies against chromogranin A. These antibodies were used both for immunocytochemistry and for the development of a specific and sensitive radioimmunoassay for chromogranin A and its fragments. Measurements of plasma chromogranin A by radioimmunoassay appeared to be a better marker for tumour growth than were measurements of chromogranin A in the urine.
Journal of Endocrinology (1993) 139, 329–337
This article has been cited by other articles:
|
|
 |
|
  S. Ekeblad, B. Skogseid, K. Dunder, K. Oberg, and B. Eriksson Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution Clin. Cancer Res., December 1, 2008; 14(23): 7798 - 7803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E S Ardill Circulating markers for endocrine tumours of the gastroenteropancreatic tract Ann Clin Biochem, November 1, 2008; 45(6): 539 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L Cunningham, E. T Janson, S. Agarwal, L. Grimelius, and M. Stridsberg Tachykinins in endocrine tumors and the carcinoid syndrome Eur. J. Endocrinol., September 1, 2008; 159(3): 275 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ekeblad, A. Sundin, E. T. Janson, S. Welin, D. Granberg, H. Kindmark, K. Dunder, G. Kozlovacki, H. Orlefors, M. Sigurd, et al. Temozolomide as Monotherapy Is Effective in Treatment of Advanced Malignant Neuroendocrine Tumors Clin. Cancer Res., May 15, 2007; 13(10): 2986 - 2991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Borglum, J. F. Rehfeld, L. B. Drivsholm, and L. Hilsted Processing-Independent Quantitation of Chromogranin A in Plasma from Patients with Neuroendocrine Tumors and Small-Cell Lung Carcinomas Clin. Chem., March 1, 2007; 53(3): 438 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Portela–Gomes and M. Stridsberg Selective Processing of Chromogranin A in the Different Islet Cells in Human Pancreas J. Histochem. Cytochem., April 1, 2001; 49(4): 483 - 490. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Ischia, R. W. Gasser, R. Fischer-Colbrie, U. Eder, A. Pagani, L. X. Cubeddu, P. Lovisetti-Scamihorn, G. Finkenstedt, A. Laslop, and H. Winkler Levels and Molecular Properties of Secretoneurin-Immunoreactivity in the Serum and Urine of Control and Neuroendocrine Tumor Patients J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 355 - 360. [Abstract] [Full Text]
|
|
|
|
|
|
D. Granberg, M. Stridsberg, R. Seensalu, B. Eriksson, G. Lundqvist, K. Öberg, and B. Skogseid Plasma Chromogranin A in Patients with Multiple Endocrine Neoplasia Type 1 J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2712 - 2717. [Abstract] [Full Text]
|
|
|
|
|
|
T. Borglum Jensen, L. Hilsted, and J. F. Rehfeld Library of Sequence-specific Radioimmunoassays for Human Chromogranin A Clin. Chem., April 1, 1999; 45(4): 549 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Wassberg, F. Hedborg, E. Skoldenberg, M. Stridsberg, and R. Christofferson Inhibition of Angiogenesis Induces Chromaffin Differentiation and Apoptosis in Neuroblastoma Am. J. Pathol., February 1, 1999; 154(2): 395 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Gadroy, M. Stridsberg, C. Capon, J.-C. Michalski, J.-M. Strub, A. Van Dorsselaer, D. Aunis, and M.-H. Metz-Boutigue Phosphorylation and O-Glycosylation Sites of Human Chromogranin A (CGA79-439) from Urine of Patients with Carcinoid Tumors J. Biol. Chem., December 18, 1998; 273(51): 34087 - 34097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Granberg, E Wilander, M Stridsberg, G Granerus, B Skogseid, and K Oberg Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids Gut, August 1, 1998; 43(2): 223 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Portela-Gomes, M. Stridsberg, H. Johansson, and L. Grimelius Complex Co-localization of Chromogranins and Neurohormones in the Human Gastrointestinal Tract J. Histochem. Cytochem., June 1, 1997; 45(6): 815 - 822. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
